Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.
about
Experience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov--NCT02247141)Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic reviewEfficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.Antimicrobial prophylaxis.Antibody deficiency associated with gold treatment: natural history and management in 22 patientsManagement of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases.Clinical and immunological features of 65 Iranian patients with common variable immunodeficiencyCurrent perspectives on common variable immunodeficiency (CVID).Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.Primary immune deficiencies - principles of care.Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93.Survey of infection in patients receiving antibody replacement treatment for immune deficiency.Primary antibody deficiency and diagnostic delay.Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratoryHuman normal immunoglobulin in the treatment of primary immunodeficiency diseases.Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003).Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.Use of subcutaneous immunoglobulin in primary immune deficiencies.Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy.Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.Antibody-based therapies as anti-infective agents.A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation.Intravenous immune globulin in primary immunodeficiency.Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s).Expression of activation-induced cytidine deaminase gene in B lymphocytes of patients with common variable immunodeficiency.IgE deficiency may indicate underlying hypogammaglobulinaemia?Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy.The Role of the Immune Response in the Pathogenesis of Bronchiectasis.Current practice and future directions in clinical immunology.
P2860
Q28546873-04F73EE6-2996-42D7-AD23-6D7DDD60824CQ28755847-02DDCC2F-F6AD-45D5-A864-F6BF11127382Q33346197-7A9CF797-C406-44C1-8833-0C0DEAB3D20AQ33543761-86B20572-E328-4A1C-8A82-2348E50B7CD1Q33579212-3D6E3FE6-B525-4B97-AFB4-C40C363E57AAQ33692022-2C4D5C53-FAAA-43CB-94BA-8264D01007FFQ33910840-CD030989-B270-4C94-BBB3-18BCC40822D3Q34255299-F3E046C7-28F4-4515-AF41-95F3B0D7957AQ34620111-D37B65BA-AA7B-4E9F-93CE-A9547C79275DQ34700023-C4B7D7FD-B222-4C27-B46B-AD25004403EFQ34779011-477ACAF4-2804-4E31-8647-0BAE1B0BA537Q34798791-BD6DFDB2-58A9-49EC-AE95-710665073F8CQ35586332-72373678-73AC-449A-856E-81F11CE19DFDQ35588514-4207B652-E4E4-4A71-9324-A89689D7370EQ35588517-997C5740-FC7A-4801-BE04-69F5068DC9C4Q35905557-257254D7-D617-451E-BDE0-9F8EB5DE1402Q36135599-9B0903C3-8B79-41D1-A289-792AA4D8ACC5Q36777795-DC630C31-D657-49CB-8CEA-9F2CA43D584EQ36791300-E8FD13F3-655C-4AFF-9E12-7AA2B155D135Q37217385-39A415AC-2DFF-4570-833B-CBAE509151A8Q37364113-35A737C3-0FDF-4947-9CF7-476F406B9808Q38122120-2668EDA5-7C8C-4410-A4D7-58B0A931653EQ38420971-5C33F3B3-E6D6-4BF1-83BE-31454D7BB6B5Q39216839-F7935AEA-E95F-4E4B-B475-6CE243CE56F8Q40356366-86613D72-BAB9-41D5-8A20-4BF71781B968Q40673451-83B8A31A-9365-42EE-B3D1-DDFCEB146802Q41077914-BC93FB02-95B0-4CB3-9ACE-283392E57B0EQ41855727-07741732-6B8A-40DC-AFE5-644DA67D18E6Q51712817-F72A131A-EA32-45FA-BC2E-5140FD41FFE8Q51926657-32C84328-E2D6-4036-A77C-B3B7A48792F8Q55029817-FBC31E9F-C010-4290-8A12-B994C52BB78CQ55612370-6168F4E2-2093-46AB-9AE7-3F647CE646A7
P2860
Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Consensus on diagnosis and man ...... Primary Antibody Deficiencies.
@en
type
label
Consensus on diagnosis and man ...... Primary Antibody Deficiencies.
@en
prefLabel
Consensus on diagnosis and man ...... Primary Antibody Deficiencies.
@en
P2860
P356
P1433
P1476
Consensus on diagnosis and man ...... Primary Antibody Deficiencies.
@en
P2093
P2860
P304
P356
10.1136/BMJ.308.6928.581
P407
P577
1994-02-01T00:00:00Z